Skip to main content

Advertisement

Log in

Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Onychomycosis refers to fungal infection of the nail and is commonly caused by dermatophytes, while yeasts and non-dermatophytic molds (NDM) are increasingly recognized as pathogens in nail infections. The present study was done to delineate molecular epidemiology of Fusarium onychomycosis in India. Five hundred nail samples of Indian patients clinically suspected of onychomycosis were subjected to direct microscopy and fungal culture. Representative Fusarium isolates were further identified to species level by multi-locus sequencing for internal transcribed spacer, translation elongation factor 1 alpha (tef1-α) and RNA polymerase II subunit (rpb2) regions (primer pairs: ITS1/ITS4, EF1/EF2, 5f2/7cr, respectively). These representative strains were also tested for in vitro antifungal susceptibility by the broth microdilution method. Members of the genus Fusarium proved to be the most common NDM responsible for onychomycosis. The Fusarium spp. responsible for onychomycosis belonged to the Fusarium solani species complex (F. keratoplasticum and F. falciforme) and Fusarium fujikuroi species complex (F. proliferatum, F. acutatum and F. sacchari). Antifungal susceptibility results indicated that amphotericin B was the most effective antifungal across all isolates (MIC ranging 0.5–2 mg/L), followed by voriconazole (MIC ranging 1–8 µg/ml). However, a large variation was shown in susceptibility to posaconazole (MIC ranging 0.5 to >16 µg/ml). To conclude, we identified different Fusarium spp. responsible for onychomycosis in India with variation within species in susceptibility to antifungal agents, showing that fusariosis requires correct and prompt diagnosis as well as antifungal susceptibility testing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev. 1995;8:240–59.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Murray SC, Dawber RP. Onychomycosis of toenails: orthopedic and podiatric considerations. Australas J Dermatol. 2002;43:105–12.

    Article  PubMed  Google Scholar 

  3. Shobhanadari C, Rao DT, Babu KS. Clinical and mycological study of superficial fungal infection at Government General Hospital: Guntur and their response to treatment with Hamycin, Dermatostatin and Dermamycin. Indian J Dermatol Venerol. 1970;36:209–14.

    Google Scholar 

  4. Kaur R, Kashyap B, Bhalla P. Onychomycosis-epidemiology, diagnosis and management. Indian J Med Microbiol. 2008;26:108–16.

    Article  CAS  PubMed  Google Scholar 

  5. Grover C, Khurana A. Onychomycosis: newer insights in pathogenesis and diagnosis. Indian J Dermatol Venereol Leprol. 2012;78(3):263–70.

    Article  PubMed  Google Scholar 

  6. Degreef H. Clinical forms of dermatophytosis (ringworm infection). Mycopathologia. 2008;166(5–6):257–65.

    Article  PubMed  Google Scholar 

  7. Gupta AK, Drummond-Main C, Cooper EA, et al. Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. Am Acad Dermatol. 2012;66(3):494–502.

    Article  Google Scholar 

  8. Tosti A, Piraccini BM, Lorenzi S, et al. Treatment of non-dermatophyte mold and Candida onychomycosis. Dermatol Clin. 2003;21(3):491–7.

    Article  PubMed  Google Scholar 

  9. Haneke E, Roseeuw D. The scope of onychomycosis: epidemiology and clinical features. Int J Dermatol. 1999;38(Suppl 2):7–12.

    Article  PubMed  Google Scholar 

  10. van Diepeningen AD, Feng P, Ahmed S, et al. Spectrum of Fusarium infections in tropical dermatology evidenced by MLST diagnostics. Mycoses. 2015;58(1):48–57.

    Article  PubMed  Google Scholar 

  11. Rippon JW. Medical mycology. The pathogenic fungi and the pathogenic actinomycetes. 3rd ed. Philadelphia: WB Saunders; 1988.

    Google Scholar 

  12. Fisher F, Cook NB. Fundamentals of diagnostic mycology. Philadelphia, PA: WB Saunders; 1998.

    Google Scholar 

  13. English MP. Nails and fungi. Br J Dermatol. 1976;94(6):697–701.

    Article  CAS  PubMed  Google Scholar 

  14. White TJ, Bruns T, Lee S, et al. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. New York: Academic Press; 1990. p. 315–22.

    Google Scholar 

  15. Geiser DM, Jimenez-Gasco M, Kang S, et al. FUSARIUM-ID v. 1.0: a DNA sequence database for identifying Fusarium. Eur J Plant Pathol. 2004;110:473–9.

    Article  CAS  Google Scholar 

  16. Reeb V, Lutzoni F, Roux C. Contribution ofRPB2 to multilocus phylogenetic studies of the euascomycetes (Pezizomycotina, Fungi) with special emphasis on the lichen-forming Acarosporaceae and evolution of polyspory. Mol Phylogenet Evol. 2004;32(3):1036–60.

    Article  CAS  PubMed  Google Scholar 

  17. Liu YJ, Whelen S, Hall BD. Phylogenetic relationships among ascomycetes: evidence from an RNA polymerase II subunit. Mol Biol Evol. 1999;16(12):1799–808.

    Article  CAS  PubMed  Google Scholar 

  18. O’Donnell K, Sutton DA, Rinaldi MG, et al. Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol. 2010;48:3708–18.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Tamura K, Stecher G, Peterson D, et al. MEGA6: molecular Evolutionary Genetics Analysis Version 6.0. Mol Biol Evol. 2013;30:2725–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ronquist F, Teslenko M, van der Mark P, et al. MrBayes 3.2: efficient Bayesian phylogenetic inference and model choice across a large model space. Syst Biol. 2012;61:539–42.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard—Second edition. CLSI document M38-A2. 2008, CLSI, Wayne.

  22. Hwang SM, Suh KY, Ha GY. Onychomycosis due to non-dermatophytic molds. Ann Dermatol. 2012;24(2):175–80.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ahuja S, Shalini M, Charoo H. Etiological agents of Onychomycosis from a Tertiary Care Hospital in Central Delhi, India. Indian J Fundam Appl Life Sci. 2011;1(2):11–4.

    Google Scholar 

  24. Kaur R, Kashyap B, Bhalla P. A five-year survey of onychomycosis in New Delhi, India: epidemiological and laboratory aspects. Indian J Dermatol. 2007;52(1):39–42.

    Article  Google Scholar 

  25. Galletti J, Negri M, Grassi FL, et al. Fusarium spp. is able to grow and invade healthy human nails as a single source of nutrients. Eur J Clin Microbiol Infect Dis. 2015;34(9):1767–72.

    Article  CAS  PubMed  Google Scholar 

  26. Veer P, Patwardhan NS, Damle AS. Study of onychomycosis: prevailing fungi and pattern of infection. Indian J Med Microbiol. 2007;25(1):53–6.

    Article  CAS  PubMed  Google Scholar 

  27. Gupta M, Sharma NL, Kanga AK, et al. Onychomycosis: clinicomycologic study of 130 patients from Himachal Pradesh, India. Indian J Dermatol Venereol Leprol. 2007;73(6):389–92.

    Article  PubMed  Google Scholar 

  28. Lim JT, Chua HC, Goh C. Dermatophyte and nondermatophyte onychomycosis in Singapore. Australas J Dermatol. 1992;33:159–63.

    Article  CAS  PubMed  Google Scholar 

  29. Zahra LV, Gatt P, Boffa MJ, et al. Characteristics of superficial mycoses in Malta. Int J Dermatol. 2003;42:265–71.

    Article  Google Scholar 

  30. van Diepeningen AD, Al-Hatmi AMS, Brankovics B, et al. Taxonomy and clinical spectra of Fusarium species: Where do we stand in 2014? Curr Clin Microbiol Rep. 2014;1:10–8.

    Article  Google Scholar 

  31. O’Donnell K, Sutton DA, Fothergill A, et al. Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol. 2008;46(8):2477–90.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Short DP, O’Donnell K, Thrane U, et al. Phylogenetic relationships among members of the Fusarium solani species complex in human infections and the descriptions of F. keratoplasticum sp. nov. and F. petroliphilum stat.nov. Fungal Genet Biol. 2013;53:59–70.

    Article  PubMed  Google Scholar 

  33. Leslie JF, Summerell BA. The Fusarium laboratory manual. Oxford: Blackwell Publishing Ltd; 2006.

    Book  Google Scholar 

  34. Taj-Aldeen SJ, Gene J, Al Bozom I, et al. Gangrenous necrosis of the diabetic foot caused by Fusarium acutatum. Med Mycol. 2006;44(6):547–52.

    Article  PubMed  Google Scholar 

  35. Chander J, Singla N, Gulati N, et al. Fusarium sacchari: a cause of exogenous fungal endophthalmitis: first case report and review of literature. Mycopathologia. 2011;171:431–4.

    Article  PubMed  Google Scholar 

  36. Migheli Q, Balmas V, Harak H, et al. Molecular phylogenetic diversity of dermatologic and other human pathogenic fusarial isolates from hospitals in Northern and Central Italy. J Clin Microbiol. 2010;48:1076–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Al-Hatmi AMS, van Diepeningen AD, Curfs-Breuker I, et al. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex. J Antimicrob Chemother. 2015;70(4):1068–71.

    CAS  PubMed  Google Scholar 

  38. Tortorano AM, Richardson M, Roilides E, et al. European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. European Confederation of Medical Mycology. Clin Microbiol Infect. 2014;20(Suppl 3):27–46.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are thankful to Dr. Arunaloke Chakrabarty, Professor Department of Medical Microbiology, and Centre of Advanced Research in Medical Mycology, Post Graduate Institute of Medical Education and Research, Chandigarh, India, for confirming our isolates.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shukla Das.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gupta, C., Jongman, M., Das, S. et al. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India. Mycopathologia 181, 497–504 (2016). https://doi.org/10.1007/s11046-016-0014-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-016-0014-7

Keywords

Navigation